Sex Differences in Reported Adverse Drug Reactions to COVID-19 Drugs in a Global Database of Individual Case Safety Reports
ConclusionReview of a global database of suspected ADR reports revealed sex differences in the reporting patterns for drugs used in the treatment of COVID-19. Patterns of ADR sex differences need further elucidation.
Source: Drug Safety - Category: Drugs & Pharmacology Source Type: research
More News: Azithromycin | China Health | Clinical Trials | Coronavirus | COVID-19 | Databases & Libraries | Diarrhoea | Drugs & Pharmacology | Electrocardiogram | Hepatitis | Hydroxychloroquine | International Medicine & Public Health | Kaletra | Norvir | Pain | Pandemics | Respiratory Medicine | SARS | Urology & Nephrology | WHO | Zithromax